AzTrials
AzTrials

StrokeNCT00509119

ICP Waveform Analysis in Stroke Patients

An observational study of Stroke, run by Oslo University Hospital at 1 site in Norway.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This is a study on how acute clinical state and final clinical outcome in patients with stroke (exclusive subarachnoid hemorrhage) relate to ICP/ABP-derived pressure waveform parameters recorded during intensive care management. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
How many people
0 participants
Where
1 siteNorway
Study dates
Dec 2006to Dec 2008
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Acute ICH

Who may be able to join

  • Acute apoplexy

Who cannot join

  • Subarachnoidal bleeding

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Rikshospitalet - Radiumhospitalet HF

    Oslo

Other trials in Norway

About this study

Official title: Retrospective ICP Waveform Analysis in Stroke Patients Followed Prospectively

This is a study on how acute clinical state and final clinical outcome in patients with stroke (exclusive subarachnoid hemorrhage) relate to ICP/ABP-derived pressure waveform parameters recorded during intensive care management.

Read the detailed description

Aim of study:

  • Prospectively collect clinical and radiological data as well as management data.
  • Perform retrospective analysis of ICP/ABP recordings (mean ICP, mean ICP wave amplitude, mean ABP, mean ABP wave amplitude, CPP)
  • Relate the prospectively collected data with results of retrospective pressure analysis.
Conditions
Stroke
Keywords
apoplexia, Intracranial and intraarterial pressure curves in acute apoplectic patients
Medical subject headings
Stroke

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical outcome

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2007 (estimated)
  2. Study startDec 2006
  3. Study completionDec 2008 (estimated)

Why it stopped: Change of workplace for leading investigator, not replaced

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00509119
Sponsor's protocol ID
1-engum
Status last verified
Oct 2010
First submitted
30 Jul 2007
Last updated
27 Apr 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 27 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical outcome (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in